Fasting blood glucose target achievement

1 paper1 finding

Humans1

Interventions

1

GLP-1 receptor agonists

upin humans1

1 study

GLP-1 receptor agonists improve fasting blood glucose target achievement in humans (80.0% vs 55.0%).
Human trialin liver transplant recipients with diabetes
Safety and effectiveness of GLP-1 receptor agonists and SGLT-2 inhibitors in liver transplant recipients with diabetes
Clinics and research in hepatology and gastroenterology6 Aug 2026

More on GLP-1 receptor agonists

Latest

1 in 12 months

Clinics and Research in Hepatology and Gastroenterology7 Aug

Safety and effectiveness of GLP-1 receptor agonists and SGLT-2 inhibitors in liver transplant recipients with diabetes

Cohort study of 41 peopleSGLT2 inhibitors